Beam Therapeutics Inc. · NASDAQ:BEAM
Bellon Christine received 20,000 Beam Therapeutics Inc. shares as an award (Form 4)
Traded Mar 31, 2026 · Filed Apr 2, 2026
On Mar 31, 2026, Bellon Christine (Chief Legal Officer) received 20,000 Beam Therapeutics Inc. shares as an award, leaving 115,667 shares. Filed Apr 2, 2026 (Form 4).
- Awarded
- 20,000 shares
- Holding after
- 115,667 shares
- Trading plan
- No
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Award | 20,000 | 115,667 | Direct |
Source
Related
- Beam Therapeutics Inc.
- Bellon Christine
- Beam Therapeutics Inc. shareholders
- Form 4 · Bellon Christine · Apr 6, 2026
- Form 4 · Evans John M. · Oct 16, 2026
- Form 4 · Cavanagh Bethany J · Oct 2, 2026
- Form 4 · Ciaramella Giuseppe · Sep 25, 2026
- Schedule 13G/A · ARK Investment Management LLC · Aug 14, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026